Bergen, Norway, 14 May 2018 - The Annual General Meeting of BerGenBio ASA was
held at Møllendalsbakken 9, 5009 Bergen, on 14 May 2018.
All proposals were resolved as presented in the notice convening the annual
general meeting distributed on 23 April 2018, as further set out in the minutes
from the annual general meeting attached hereto.
For further information, please contact:
Richard Godfrey
CEO, BerGenBio ASA
ir@bergenbio.com
Rune Skeie
CFO, BerGenBio ASA
rune.skeie@bergenbio.com
+47 917 86 513
Forward looking statements
This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.